Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor × Blood Component Removal × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Multiple Myeloma 9 Lymphoma, Non-Hodgkin 6 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma 4 Leukemia, Myeloid, Acute 4 Myelodysplastic Syndromes 3 Melanoma 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Carcinoma, Non-Small-Cell Lung 3 Ovarian Neoplasms 2 Neoplasms, Plasma Cell 2 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2 Leukemia 2 Immunoglobulin Light-chain Amyloidosis 2 Hodgkin Disease 2 Glioma 2 Burkitt Lymphoma 2 Wilms Tumor 1 Triple Negative Breast Neoplasms 1 Solid Tumor 1 Sarcoma 1 Primary Myelofibrosis 1 Philadelphia Chromosome 1 Pancreatic Neoplasms 1 Osteosarcoma 1 Neuroblastoma 1 Neoplasms 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Mesothelioma, Malignant 1

Interventions

pembrolizumab 11 Injections 11 Paclitaxel 10 Docetaxel 9 Cisplatin 8 Capecitabine 8 Nivolumab 7 Fluorodeoxyglucose F18 7 Bevacizumab 7 toripalimab 6 senaparib 6 atezolizumab 6 Irinotecan 6 Fluorouracil 6 tislelizumab 5 Cyclophosphamide 5 apatinib 4 Leucovorin 4 Ipilimumab 4 Gemcitabine 4 spartalizumab 3 pertuzumab 3 olaparib 3 fludarabine 3 camrelizumab 3 Rifampin 3 Radiosurgery 3 Oxaliplatin 3 Midazolam 3 Itraconazole 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07137312 2025-12-23

Ex Vivo Expansion (ACT-X)

Mayo Clinic

Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡